Kingdon Capital Management, L.L.C. Adicet Bio, Inc. Transaction History

Kingdon Capital Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.26 - $20.81 $2.82 Million - $5.72 Million	-275,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $994,950 - $2.36 Million	135,000 Added 96.43%	275,000 $4.81 Million
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $157,250 - $248,250	25,000 Added 21.74%	140,000 $1.1 Million
Q2 2021 Aug 16, 2021	BUY	$9.19 - $15.93 $137,850 - $238,950	15,000 Added 15.0%	115,000 $1.18 Million
Q1 2021 May 17, 2021	BUY	$12.12 - $17.17 $1.21 Million - $1.72 Million	100,000 New	100,000 $1.31 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $38.8M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.